Jeffery S. Thompson - 08 Jun 2022 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
Director
Signature
/s/ Jeffery S. Thompson
Issuer symbol
ANIK
Transactions as of
08 Jun 2022
Net transactions value
$0
Form type
4
Filing time
10 Jun 2022, 16:15:52 UTC
Previous filing
15 Mar 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Award $0 +7,954 +46% $0.000000 25,075 08 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jeffery S. Thompson is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2023 annual meeting of the Company's stockholders or June 8, 2023.